The Weekly: Faulty BRCA genes linked to prostate and pancreatic cancers, blood test could detect recurrent melanoma and more

Published on January 28, 2022

The Weekly

January is Cervical Health Awareness Month (some organizations also recognize this as Cervical Cancer Awareness Month). Be on the lookout for news from us about cervical health throughout the month of January. Learn more about cervical cancer.

Feature story

Faulty BRCA genes linked to prostate and pancreatic cancers

Faulty BRCA genes linked to prostate and pancreatic cancers

TUESDAY, January 25, 2022 (ScienceDaily) Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that affect men.

A study published today in the Journal of Clinical Oncology has provided the strongest evidence to date of these links and helped researchers estimate more accurately the associated risk.

In other news…

There’s a new frontier in detecting cancer: blood tests
January 26, The Boston Globe


Late-stage colon cancer showing up in more younger adults. ‘Get screened,’ doctor urges
January 27, USA Today


Blood test could detect recurrent melanoma up to a year before scans
January 24, Times & Star

Cervical Cancer Disproportionately Affects Black Women, According To New Study
January 26, BET


Foundation news


Join us for the 13th Annual Prevent Cancer Health Fair and 5k Walk/Run on Sunday, March 13 at Nationals Park in the beautiful Capitol Riverfront neighborhood in D.C. This year, all kids 12 and under are FREE so, bring your entire family—dogs, too—for a day of exercise, education and fun. Sign up by Monday, January 31 for early bird pricing!

Learn more.


Browse The Weekly archive

Sign up to get the latest about cancer prevention and early detection directly in your inbox.